Patents by Inventor Kirsten Bjergarde

Kirsten Bjergarde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PIKFYVE KINASE INHIBITORS
    Publication number: 20230135152
    Abstract: The present invention relates to compounds useful as inhibitors of phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) as well as their use for treating diseases and disorders associated with PIKfyve.
    Type: Application
    Filed: February 11, 2021
    Publication date: May 4, 2023
    Inventors: Martin SMRCINA, Ronghua LI, Anil NAIR, Paul AUGUST, Kirsten BJERGARDE, Jennifer LUDINGTON
  • PIKFYVE KINASE INHIBITORS
    Publication number: 20200199136
    Abstract: The present invention relates to compounds of formula (I) (shown below) useful as inhibitors of phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) as well as their use for treating diseases and disorders associated with PIKfyve.
    Type: Application
    Filed: August 28, 2018
    Publication date: June 25, 2020
    Inventors: Martin Smrcina, Ronghua Li, Anil Nair, Paul August, Kirsten Bjergarde
  • Substituted pyrazoles, compositions containing these, method of production and use
    Patent number: 8420824
    Abstract: The disclosure relates to a compound of formula (I): and salts thereof; wherein Ar, L, A, X, R1, R2, R3, R4a, R4b, and R5 are as defined in the disclosure; compositions comprising said compounds, methods for their preparation, intermediates thereto, and the use thereof, particularly as drugs.
    Type: Grant
    Filed: June 9, 2011
    Date of Patent: April 16, 2013
    Assignee: Sanofi
    Inventors: Kirsten Bjergarde, Mark Dodson, Jacques Mauger, Anil Nair, Marcel Patek, Michel Tabart
  • Substituted pyrazoles, compositions containing these, method of production and use
    Patent number: 8410286
    Abstract: The disclosure relates to a compound of formula (I): and salts thereof; wherein Ar, L, A, X, R1, R2, R3, R4a, R4b, and R5 are as defined in the disclosure; compositions comprising said compounds, methods for their preparation, intermediates thereto, and the use thereof, particularly as drugs.
    Type: Grant
    Filed: June 9, 2011
    Date of Patent: April 2, 2013
    Assignee: Sanofi-Aventis
    Inventors: Kirsten Bjergarde, Mark Dodson, Jacques Mauger, Anil Nair, Marcel Patek, Michel Tabart
  • 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
    Patent number: 8163768
    Abstract: This invention relates to compounds of formula (I) to processes for the preparation of such compounds, to pharmaceutical compositions comprising such compounds, and to methods of treatment comprising administering of such compounds.
    Type: Grant
    Filed: January 15, 2008
    Date of Patent: April 24, 2012
    Assignee: Aventis Pharma S.A..
    Inventors: Jacques Mauger, Anil Nair, Nina Ma, Kirsten Bjergarde, Bruno Filoche-Romme, Odile Angouillant-Boniface, Serge Mignani, Jean-Christophe Carry, Francois Clerc, Herve Minoux, Laurent Schio, Cecile Combeau
  • 7-substituted aza-indazoles, compositions containing same, production method and use thereof
    Patent number: 8058290
    Abstract: The disclosure relates to compounds of formula (I): which modulate the activity of proteins, particularly kinases, and to compositions containing the same, and to the use thereof as medicaments, in particular as anticancer agents.
    Type: Grant
    Filed: January 29, 2008
    Date of Patent: November 15, 2011
    Assignee: Aventis Pharma S.A.
    Inventors: Kirsten Bjergarde, Anil Nair, Marcel Patek, Martha Ackerman-Berrier, Martin Smrcina, Eric Bacque, Michel Tabart, Baptiste Ronan, Vincent Leroy, Fabrice Viviani, Mark Dodson, Catherine Souaille
  • SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE
    Publication number: 20110237641
    Abstract: The disclosure relates to a compound of formula (I): and salts thereof; wherein Ar, L, A, X, R1, R2, R3, R4a, R4b, and R5 are as defined in the disclosure; compositions comprising said compounds, methods for their preparation, intermediates thereto, and the use thereof, particularly as drugs.
    Type: Application
    Filed: June 9, 2011
    Publication date: September 29, 2011
    Inventors: Kirsten BJERGARDE, Mark DODSON, Jacques MAUGER, Anil NAIR, Marcel PATEK, Michel TABART
  • SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE
    Publication number: 20110237801
    Abstract: The disclosure relates to a compound of formula (I): and salts thereof; wherein Ar, L, A, X, R1, R2, R3, R4a, R4b, and R5 are as defined in the disclosure; compositions comprising said compounds, methods for their preparation, intermediates thereto, and the use thereof, particularly as drugs.
    Type: Application
    Filed: June 9, 2011
    Publication date: September 29, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Kirsten BJERGARDE, Mark DODSON, Jacques MAUGER, Anil NAIR, Marcel PATEK, Michel TABART
  • Substituted pyrazoles, compositions containing these, method of production and use
    Patent number: 7989439
    Abstract: The disclosure relates to a compound of formula (I): and salts thereof; wherein Ar, L, A, X, R1, R2, R3, R4a, R4b, and R5 are as defined in the disclosure; compositions comprising said compounds, methods for their preparation, intermediates thereto, and the use thereof, particularly as drugs.
    Type: Grant
    Filed: May 8, 2009
    Date of Patent: August 2, 2011
    Assignee: Sanofi-Aventis
    Inventors: Kirsten Bjergarde, Mark Dodson, Jacques Mauger, Anil Nair, Marcel Patek, Michel Tabart
  • Pyrazolopyridine derivatives as inhibitors of ?-Adrenergic receptor kinase 1
    Patent number: 7910602
    Abstract: The invention relates to 6-amido substituted pyrazolopyridine derivatives of the formula (I) useful as inhibitors of beta-adrenergic receptor kinase 1 (?ARK-1), compositions containing such compounds and their use for the treatment and prevention of chronic heart failure, hypertension, myocardial ischemia and hepatitis C virus (HCV) infections, and for the prevention of opiate addiction.
    Type: Grant
    Filed: December 20, 2007
    Date of Patent: March 22, 2011
    Assignee: Sanofi-Aventis
    Inventors: Henning Steinhagen, Jochen Huber, Kurt Ritter, Bernard Pirard, Kirsten Bjergarde, Marcel Patek, Martin Smrcina, Linli Wei
  • SUBSTITUTED PYRAZOLES, COMPOSITIONS CONTAINING THESE, METHOD OF PRODUCTION AND USE
    Publication number: 20090291984
    Abstract: The disclosure relates to a compound of formula (1): and salts thereof; wherein Ar, L, A, X, R1, R2, R3, R4a, R4b, and R5 are as defined in the disclosure; compositions comprising said compounds, methods for their preparation, intermediates thereto, and the use thereof, particularly as drugs.
    Type: Application
    Filed: May 8, 2009
    Publication date: November 26, 2009
    Applicant: sanofi-aventis
    Inventors: Kirsten Bjergarde, Mark Dodson, Jacques Mauger, Anil Nair, Marcel Patek, Michel Tabart
  • 1,4-Dihydropyridine-Fused Heterocycles, Process for Preparing the Same, Use and Compositions Containing Them
    Publication number: 20080261969
    Abstract: This invention relates to compounds of formula (I) to processes for the preparation of such compounds, to pharmaceutical compositions comprising such compounds, and to methods of treatment comprising administering of such compounds.
    Type: Application
    Filed: January 15, 2008
    Publication date: October 23, 2008
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Jacques MAUGER, Anil NAIR, Nina MA, Kirsten BJERGARDE, Bruno FILOCHE-ROMME, Odile ANGOUILLANT-BONIFACE, Serge MIGNANI, Jean-Christophe CARRY, Francois CLERC, Herve MINOUX, Laurent SCHIO, Cecile COMBEAU
  • Pyrazolopyridine derivatives as inhibitors of beta-Adrenergic Receptor Kinase 1
    Publication number: 20080227777
    Abstract: The invention relates to 6-amido substituted pyrazolopyridine derivatives of the formula (I) useful as inhibitors of beta-adrenergic receptor kinase 1 (?ARK-1), compositions containing such compounds and their use for the treatment and prevention of chronic heart failure, hypertension, myocardial ischemia and hepatitis C virus (HCV) infections, and for the prevention of opiate addiction.
    Type: Application
    Filed: December 20, 2007
    Publication date: September 18, 2008
    Applicant: SANOFI-AVENTIS
    Inventors: Henning STEINHAGEN, Jochen HUBER, Kurt RITTER, Bernard PIRARD, Kirsten BJERGARDE, Marcel PATEK, Martin SMRCINA, Linli WEI
  • 7-Substituted Aza-Indazoles, Compositions Containing Same, Production Method and Use Thereof
    Publication number: 20080182844
    Abstract: The disclosure relates to compounds of formula (I): which modulate the activity of proteins, particularly kinases, and to compositions containing the same, and to the use thereof as medicaments, in particular as anticancer agents.
    Type: Application
    Filed: January 29, 2008
    Publication date: July 31, 2008
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Kirsten BJERGARDE, Anil NAIR, Marcel PATEK, Martha ACKERMAN-BERRIER, Martin SMRCINA, Eric BACQUE, Michel TABART, Baptiste RONAN, Vincent LEROY, Fabrice VIVIANI, Mark DODSON, Catherine SOUAILLE